Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-20-000022
Filing Date
2020-09-25
Accepted
2020-09-25 08:12:17
Documents
8
Period of Report
2020-09-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea127329-6k_therapixbio.htm 6-K 15410
2 NOTICE AND PROXY STATEMENT FOR THE SPECIAL GENERAL MEETING TO BE HELD ON OCTOBER ea127329ex99-1_therapix.htm EX-99.1 29655
3 PROXY CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON OCTOBER 16, 2020 ea127329ex99-2_therapix.htm EX-99.2 9282
4 VOTING INSTRUCTION CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON OCTOBER 16 ea127329ex99-3_therapix.htm EX-99.3 1640
5 GRAPHIC ex99-1_001.jpg GRAPHIC 6368
6 GRAPHIC ex99-2_001.jpg GRAPHIC 16184
7 GRAPHIC ex99-3_001.jpg GRAPHIC 110471
8 GRAPHIC ex99-3_002.jpg GRAPHIC 99294
  Complete submission text file 0001013762-20-000022.txt   377443
Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 201196827
SIC: 2834 Pharmaceutical Preparations